| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
 |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
IDEC PHARMACEUTICALS CORP / DE [ IDPH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 09/02/2003 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
|||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 03/31/2003 | J(1) | 40 | A | $29.087 | 5,266 | D | |||
| Common Stock | 06/30/2003 | J(1) | 18 | A | $28.866 | 5,284 | D | |||
| Common Stock | 08/29/2003 | M | 1,490 | A | $4.3542 | 6,774 | D | |||
| Common Stock | 08/29/2003 | S | 1,490 | D | $34.6803 | 5,284 | D | |||
| Common Stock | 08/29/2003 | M | 680 | A | $7.4167 | 5,964 | D | |||
| Common Stock | 08/29/2003 | S | 680 | D | $34.6803 | 5,284 | D | |||
| Common Stock | 08/29/2003 | M | 2,100 | A | $5.25 | 7,384 | D | |||
| Common Stock | 08/29/2003 | S | 2,100 | D | $34.6803 | 5,284 | D | |||
| Common Stock | 08/29/2003 | M | 4,250 | A | $9.5104 | 9,534 | D | |||
| Common Stock | 08/29/2003 | S | 4,250 | D | $34.6803 | 5,284 | D | |||
| Common Stock | 08/29/2003 | M | 9,105 | A | $16.2604 | 14,389 | D | |||
| Common Stock | 08/29/2003 | S | 9,105 | D | $34.6803 | 5,284 | D | |||
| Common Stock | 09/02/2003 | S | 9,895 | D | $33.8351 | 7,100 | I | by Trust | ||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Incentive Stock Option (right to buy)(2) | $4.3542 | 08/29/2003 | M | 1,490(3) | 04/16/1997(3) | 04/23/2006 | Common Stock | 1,490 | (2) | 8,510 | D | ||||
| Incentive Stock Option (right to buy)(2) | $5.25 | 08/29/2003 | M | 2,100(4) | 04/01/1999(4) | 05/20/2008 | Common Stock | 2,100 | (2) | 2,940 | D | ||||
| Incentive Stock Option (right to buy)(2) | $7.4167 | 08/29/2003 | M | 680(5) | 12/16/1998(5) | 02/19/2008 | Common Stock | 680 | (2) | 24,920 | D | ||||
| Incentive Stock Option (right to buy)(2) | $9.5104 | 08/29/2003 | M | 4,250(6) | 04/01/2000(6) | 04/20/2009 | Common Stock | 4,250 | (2) | 10,750 | D | ||||
| Incentive Stock Option (right to buy)(2) | $16.2604 | 08/29/2003 | M | 9,105(7) | 09/16/2000(7) | 09/23/2009 | Common Stock | 9,105 | (2) | 8,895 | D | ||||
| Explanation of Responses: |
| 1. Acquisition of shares under the Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3(c). |
| 2. Granted under Issuer's Employee Stock Option Plan, in an exempt transaction under SEC rule 16b-3(d). |
| 3. Option was originally granted for 12,000 shares and became exercisable as follows: 25% of the optioned shares on 4/16/97 and as to the balance of the shares in 36 equal monthly installments thereafter. |
| 4. Option was originally granted for 5,040 shares and became exercisable as follows: 25% of the optioned shares on 4/1/99 and as to the balance of the shares in 36 equal monthly installments thereafter. |
| 5. Option was originally granted for 33,600 shares and became exercisable as follows: 25% of the optioned shares on 12/16/98 and as to the balance of the shares in 36 equal monthly installments thereafter. |
| 6. Option was originally granted for 15,000 shares and became exercisable as follows: 25% of the optioned shares on 4/1/00 and as to the balance of the shares in 36 equal monthly installments thereafter. |
| 7. Option was originally granted for 18,000 shares and became exercisable as follows: 25% of the optioned shares on 9/16/00 and as to the balance of the shares in 36 equal monthly installments thereafter. |
| By: Pamela A. Blas For: Edward Rodriguez | 09/03/2003 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENT, that the undersigned hereby constitutes and appoints John Dunn , and Pamela Blas , and each of them, his true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of IDEC Pharmaceuticals Corporation (the "Company"), any and all Forms 3, 4 and 5 required to be filed by the undersigned in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that no such attorney-in-fact, in serving such capacity at the request of the undersigned, is hereby assuming, nor is the Company hereby assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of 27 day of February, 2003.
BY /s/EDWARD RODRIGUEZ Edward Rodriguez
Vice President & Controller